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ABSTRACT
Although the neuropeptide oxytocin exhibits many of the characteristics that would support its use as 
an anorectic agent for overeaters, studies of oxytocin’s effectiveness at reducing eating in humans 
remain limited. In a double-blind, placebo-controlled crossover study, under the pretext of examining 
oxytocin’s effects on various aspects of sensory perception, 20 men were given 24 IU of oxytocin and 
took a taste test of sweet, salty, and neutral snacks 45 minutes later. Participants self-rated appetite, 
anxiety, and other mood parameters, and then were left alone for 10 minutes with the pre-weighed 
snack food and invited to help themselves. To minimize the influence of hunger-driven eating, lunch 
had been provided immediately after oxytocin administration. In line with Ott et al. (2013), oxytocin 
significantly reduced the consumption of sweet foods; however, it also reduced consumption of salty 
snacks. Self-reported anxiety did not differ across drug conditions. The study is the first to 
demonstrate an effect of oxytocin on snack eating at 45 minutes post administration and on salty 
snacks. The anorectic efficacy of oxytocin after 45 minutes cannot easily be explained by the same 
mechanism as the one presumed to underpin its effects in previous studies that adopted much longer 
intervals between drug administration and testing. 
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2ABSTRACT
Although the neuropeptide oxytocin exhibits many of the characteristics that would support 
its use as an anorectic agent for overeaters, studies of oxytocin’s effectiveness at reducing 
eating in humans remain limited. In a double-blind, placebo-controlled crossover study, under 
the pretext of examining oxytocin’s effects on various aspects of sensory perception, 20 men 
were given 24 IU of oxytocin and took a taste test of sweet, salty, and neutral snacks 45 
minutes later. Participants self-rated appetite, anxiety, and other mood parameters, and then 
were left alone for 10 minutes with the pre-weighed snack food and invited to help 
themselves. To minimize the influence of hunger-driven eating, lunch had been provided 
immediately after oxytocin administration. In line with Ott et al. (2013), oxytocin 
significantly reduced the consumption of sweet foods; however, it also reduced consumption 
of salty snacks. Self-reported anxiety did not differ across drug conditions. The study is the 
first to demonstrate an effect of oxytocin on snack eating at 45 minutes post administration 
and on salty snacks. The anorectic efficacy of oxytocin after 45 minutes cannot easily be 
explained by the same mechanism as the one presumed to underpin its effects in previous 
studies that adopted much longer intervals between drug administration and testing. 
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31. INTRODUCTION
Oxytocin is a nonapeptide hormone released from the neurohypophysis centrally and into 
systemic circulation. The hormone is traditionally associated with the physiology of 
parturition (Zeeman, Khan-Dawood, & Yusoff Dawood, 1997), but its effects on a wide 
range of processes have now been recognised, including effects on prosocial behaviour, 
memory, and anxiety (e.g. Chini, Leonzino, Sala, & Braida, 2014; Tost et al., 2010). 
Oxytocin receptors have been identified in areas of the  brain associated with reward, and 
they interact with dopamine receptors in these regions to alter motivation, including the 
motivation to eat  (Boccia, Petrusz, Suzuki, Marson, & Pedersen, 2013; Romero-Fernandez, 
Borroto-Escuela, Agnati, & Fuxe, 2013; Sabatier, Leng, & Menzies, 2013). The anorectic 
effects of oxytocin have been established in animal models: the peptide acts in the 
hypothalamus to inhibit appetite (Arletti, Benelli, & Bertolini, 1989; Leng et al., 2008; 
Maejima et al., 2009) and its effects are reversed by oxytocin antagonists (Arletti et al., 1989; 
Olson, Drutarosky, Stricker, & Verbalis, 1991; Olson et al., 1991). Oxytocin also reduces 
rodent preferences for sweet-tasting foods and prevents overconsumption of hyper-palatable 
food pellets via reward pathways in the limbic system (Amico, Vollmer, Cai, Miedlar, & 
Rinaman, 2005; Miedlar, Rinaman, Vollmer, & Amico, 2007; Mullis, Kay, & Williams, 
2013; Sclafani, Rinaman, Vollmer, & Amico, 2007).
Palatable foods containing high levels of sugar, salt, and/or fat have become commonplace in 
western diets, and a corollary is the widespread overconsumption of food, leading to obesity-
related diseases (World Health Organisation, 2015). Nearly two-thirds of the UK population 
is overweight or obese, and the proportion is increasing (UK Government, 2017). Excess 
body weight is an established contributor to a range of chronic health problems. For example, 
obese people are three times more likely to develop colon cancer than people with a BMI in 
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4the healthy range; five times more likely to develop diabetes mellitus; and two-and-a-half 
times more likely to be hypertensive (UK Government, 2017). The prevalence of food-related 
cues compounds the difficulties experienced by people struggling to moderate their food 
intake: an attentional bias towards foods and food-related stimuli is apparent not only in 
overeaters, but also in the general population (Kumar, Higgs, Rutters, & Humphreys, 2016).  
A limited but growing number of studies have examined the influence of oxytocin on weight 
management and eating, often with the aim of evaluating its potential as a treatment for 
overeating. In a small-scale study, Zhang et al. (2013) reported that 24 IU oxytocin 
administered to prediabetics 20 minutes before eating and at bedtime produced a decline in 
body mass over an eight-week period; moreover, postprandial glucose and insulin levels 
shifted towards healthier profiles. In the laboratory, Ott et al. (2013) found that oxytocin had 
no effect on the amount of breakfast eaten after an overnight fast but significantly reduced 
postprandial intake of chocolate biscuits in the same male cohort. Lawson et al. (2015) also 
measured food intake in fasted men, but found that oxytocin significantly reduced post-
fasting breakfast consumption. Differences in menu choices and in the scheduling of food 
availability might account for oxytocin’s disparate effects on food intake in fasted men across 
the two studies. Participants in the study by Lawson et al. (2015) were able to anticipate 
eating after ordering food from a menu, whereas Ott et al. (2013) provided a free-choice 
buffet from which participants could eat without delay. Sampling differences may also be 
relevant, as Lawson et al. (2015) tested a male cohort comprising both normal-weight and 
obese participants, whereas the Ott sample only included men with BMI scores in the healthy 
range. Recent findings from Thienel et al. (2016) indicated that oxytocin’s effects on eating 
were stronger in an obese subgroup of an otherwise similar sample, suggesting that 
participant body mass may affect sensitivity to the effects of oxytocin.  
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5Ott et al. (2013) and Thienel et al. (2016) also showed that biological markers of stress were 
significantly lower after oxytocin administration, a finding that is consistent with a number of 
other studies that have reported anxiolytic effects of oxytocin (Grimm et al., 2014; 
Mccullough, Churchland, & Mendez, 2013; Neumann, Torner, & Wigger, 1999). However, 
self-reported anxiety has not been measured previously in studies of oxytocin’s effects on 
eating, so it is not yet known whether subjective changes in anxiety might be related to (and 
perhaps contribute towards) oxytocin’s anorectic effect (Gibson, 2012; Wardle & Gibson, 
2016).  The present experiment, therefore, incorporated a self-report measure of anxiety.
Although neuropeptides have been found in human cerebrospinal fluid just 10 minutes after 
administration (Born et al., 2002), peak effects of oxytocin are theorised to occur between 30 
and 90 minutes post intranasal administration, and this therapeutic window is usually adopted 
in human experiments (Gossen et al., 2012). However, the two previous studies of oxytocin’s 
acute effects on postprandial snack-food intake employed a three-hour post administration 
interval, which makes their results difficult to compare directly with studies that have shown 
clinical effects of oxytocin 45 minutes after administration. For the first time in the context of 
oxytocin’s effects on eating, the present study therefore employs a much shorter (but more 
typical) latency of 45 minutes between intranasal administration and the critical test.
 
The experimental aims were fully concealed to avoid undesirable demand characteristics and 
self-selection bias; participants were unaware that the study had anything to do with eating 
motivation, metabolism or energy expenditure. As a positive control, a partial replication of 
the study by Savaskan, Ehrhardt, Schulz, Walter, and Schächinger’s (2008) was incorporated, 
testing oxytocin’s effects on emotional face recognition. Because oxytocin has been shown to 
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6reduce the post-prandial intake of sweet-tasting foods in rodents and in people, it was 
predicted that oxytocin would reduce the consumption of test foods given postprandially, 
particularly the sweet-tasting items, despite the much shorter latency between drug 
administration and testing.
2. MATERIALS AND METHODS
Design
A double-blind, placebo-controlled, randomised, and counterbalanced crossover protocol was 
implemented using a within-subjects design comprising two drug tests scheduled about a 
week apart. Participants were informed that the study investigated the effects of oxytocin on 
sensory perception across a range of modalities.
Participants
An opportunity sample of 20 healthy men aged 18 to 38 years (M = 23.5 yrs, SD = 6.5 yrs) 
with BMI scores ranging from 19.4 kg/m2 to 30.8 kg/m2 (M = 25.4 kg/m2, SD = 3.1 kg/m2) 
was recruited by word-of-mouth and/or in exchange for university course credits. Individuals 
with food allergies, diabetes, taking prescription medicines, pregnant, breastfeeding or on 
vegan diets were excluded. Altered endogenous oxytocin function is associated with high 
emotional arousal or stress (e.g. bereavement, financial windfall) so participants reporting 
such events were also excluded (Engelmann, Ebner, Landgraf, Holsboer, & Wotjak, 1999; 
Kovacs, 1986). Due to possible differences in taste sensitivity and suppressed eating 
(Audrain-McGovern & Benowitz, 2011; Gromysz-Kalkowska, Wojcik, Szubartowska, & 
Unkiewicz-Winiarczyk, 2002), regular smokers were also excluded. Participants were asked 
to avoid alcohol or non-steroidal anti-inflammatory drugs for 24 hours beforehand and to 
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7abstain from consuming food and sugary drinks for two hours before the experiment, which 
was self-reported to the researcher (one participant was excluded). In order that participants 
were not in a fasted state when given access to the test foods, a meal of sandwiches and 
crisps/chips was consumed by all participants 25 minutes before access to the critical test 
foods, and participants provided ratings of their hunger before the snack test. If participants 
indicated that they were hungry on the VAS, did not eat lunch, or did not eat all of the lunch 
and had glucose levels below 4 mmol/L, they were excluded from further participation (no 
participants were excluded for these reasons). All participants gave written, informed consent 
to take part. The study was approved by the Research Ethics Committee at Kingston 
University.  
Materials
A Salter’s electronic food scale was used to weigh food and a needle-dial scale was used to 
weigh participants. Blood glucose levels were obtained using Accu-Chek’s ‘Aviv’ hand-held 
monitor. Sham tasks used the following: Elite Healthcare’s ‘Two Point Discriminator Touch-
Test’; synthetic almond- and soap-scented smelling bottles (Caravansons LLP, Bury, UK); 
and a stopwatch. Rubin’s Romantic Love Scale (1970) and Higgs’ (2015) VAS questionnaire 
measuring levels of alertness, stress, excitement, hunger, and thirst were completed together 
with a taste VAS measuring oatcake palatability, cracker saltiness, and chocolate biscuit 
sweetness. The pitch discrimination test from Music and Neuroimaging Laboratory was 
presented online (Schlaug, 2017). Bespoke materials for the sham visual tasks included A4-
sized laminated colour prints of famous paintings and A6-sized laminated black-and-white 
pictures of castles for a ‘spot-the-difference’ test.
For lunch, each participant was provided with a meal of 546 kcal that was low in readily-
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8catabolizable sugars and consisted of a pre-packaged supermarket sandwich (Sainsbury’s 
‘Cheese and tomato on malted bread’, 424 kcal, 173 g) followed by a packet of plain 
crisps/potato chips (Hula Hoops, 121 kcal, 25 g). For the snack test, British equivalents of 
foods used in previous, similar experiments were sourced: chocolate cookies (Waitrose 
‘Triple Chunk Chocolate Chip’, 127 kcal, 25 g per unit, 450 g per bowl), TUC Classic 
Crackers (17 kcal, 5.4 g per unit, 230 g per bowl), and Sainsbury’s Oatcakes (47 kcal, 10.4 g 
per unit, 300 g per bowl). As per previous experiments, each snack-food type was matched 
for calorie content and macronutrients (see Table 1) and presented in a separate bowl filled to 
the top, in order that substantial amounts could be eaten without the bowl appearing empty.  
Chocolate Biscuits Plain Oatcakes Salty Crackers
Calories (kcal/100g) 501 488 518
Protein (g/100g) 5.7 10.7 6.9
Carbohydrate (g/100g) 59.5 56.9 54.2
Fat (g/100g) 25.8 23.5 29.9
Table 1. Nutritional values of the foods used for the taste test and the critical test of 
postprandial eating (“the snack test”)
A positive control test was included to check that oxytocin was active (in case the effects on 
eating were non-significant) by attempting to replicate its actions on an unrelated 
psychological process: memory for faces (Savaskan, Ehrhardt, Schulz, Walter, & 
Schachinger, 2008). The facial recognition test (acquisition phase) employed a set of 60 
colour pictures of Caucasian men (age range 20-65 years) with happy, angry, and neutral 
expressions on a white background. A further set of 50 colour pictures of Caucasian men (age 
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9range 20-65 years) with neutral expressions and a white background was used for the recall 
test, 20 of which featured in the acquisition set but with angry or happy expressions, and 10 
faces with neutral expressions were repeated from the acquisition set. Pictures were adapted 
from three databases: ‘A lifespan database of adult facial stimuli’ (Minear & Park, 2004), 
‘The NimStim set of facial expressions’ (Tottenham et al., 2009) and the ‘Stirling ESRC Face 
Database’ (Psychological image collection, Stirling University.2017). 
Oxytocin and placebo intranasal sprays were supplied by Victoria Pharmacy, Switzerland. 
The active ingredient of the oxytocin nasal spray was oxytocin together with excipients 
E 216, E 218 and chlorobutanol hemihydrate as preservatives. The placebo spray contained 
only excipients. A dose of 24 IU was administered, consistent with previous research (Ott et 
al., 2013).
Procedure
Participants were tested individually between 12:00 and 14:00 hrs.  After providing informed 
consent and confirming compliance with the exclusion criteria, participants began the session 
with the face recognition task. They familiarised themselves with 60 face pictures (20 neutral, 
20 happy, and 20 angry) presented in random order on a computer screen approximately 60 
cm away for 10 seconds each with a 3 second break between stimuli. Immediately afterwards, 
participants self-administered either 24 IU of oxytocin or placebo under the supervision of 
the researcher with six puffs alternated by nostril every 30 seconds. Height and body mass 
were measured, and participants completed a measure of their romantic love status (Rubin, 
1970), then 10 minutes later they were asked to eat the lunch provided. Because thirst can 
sometimes be experienced as hunger (Balleine, 1994), all participants were offered water 
with their lunch and indicated their thirst level on a VAS.
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10
To support the purpose of the study as it had been described to the participants, a range of 
sham sensory tests was then presented. An online pitch test was conducted with the 
participant seated and responding via a computer keyboard to a series of diminishing pitch 
intervals presented through the computer’s speakers (Schlaug, 2017). A two-point touch 
discrimination test on the right index finger was conducted to identify the smallest gap, in 
millimetres, that could be sensed. A smell test with smelling bottles containing synthetic soap 
or almond scents, depending on session, was then presented. Next was a timed balance test 
that required participants to stand on one leg while simultaneously ‘drawing’ counted 
numbers in the air, with their eyes shut, until they lost balance. At 30 minutes after 
oxytocin/placebo administration, a memory recognition test of the faces was undertaken. Just 
before the snack test, a finger-prick blood glucose test was conducted as a final check to 
ensure that participants did not have low blood glucose. Participants then completed a VAS 
measuring levels of ‘happiness’, ‘excitement’, ‘alertness’, ‘anxiety’, ‘hunger’, and ‘thirst’.  A 
few minutes before the covert snack test, a researcher provided the participants with small 
tasting samples of about a gram, one by one, from each of three tasting bowls containing 300 
g of neutral snacks, 230g of salty crackers, and 450g of chocolate cookies.  Participants rated 
each snack in turn on a 100 mm VAS line anchored with ‘Not at all’ and ‘Very palatable’ 
‘Very sweet’ or ‘Very salty’ for the bland, salty, and sweet test foods, respectively. The final 
sham task involved presenting one of two near-identical spot-the-difference pictures for 30 
seconds. Then the critical snack test occurred: at 45-minutes post-drug administration, the 
participant was instructed to enjoy a 10 minute ‘cognitive break’; to let his mind ‘relax’; and 
to select his preferred picture from a choice of five A4-sized prints of famous paintings. The 
experimenter announced that she would leave the room during the participant’s ‘cognitive 
break’, and it was mentioned that the test foods would be thrown away after the experiment 
due to health and safety regulations, so the participants were free to help themselves to as 
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much of the foods as they wished. The snack test period lasted 10 mins, after which the 
second spot-the-difference picture was presented for 30 seconds, and the participant was 
asked to identify the differences between the two pictures. Before participants left, they were 
asked whether they thought they had been given oxytocin or placebo. The lunch foods and 
the snack test foods were weighed before and after testing, and the test sessions lasted about 
75 mins in total. Figure 1 presents a visual timeline of the procedure.
Event sequence Time relative to drug 
administration
1.  Positive control task (memory test) -15 mins
2.  Oxytocin or Placebo given  0
3.  Height and weight measured
4.  Time of last food recorded
5.  Romantic Love Scale
6.  Set lunch +15 mins
7.  Auditory pitch test
8.  Touch discrimination test
9.  Smell test
10. Balance test
11. Positive control task (memory test) +30 mins
12. VAS self-report measures
13. Blood glucose measure 
14. Taste test +40 mins
15. Spot-the-difference picture 1
16. SNACK TEST (‘cognitive break’) +45 mins
17. Spot-the difference picture 2 +55 mins
Figure 1: Timeline of a test session 
Statistical Analyses
Paired-samples t tests were conducted to test for differences in food intake and taste measures 
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between drug conditions. Due to multiple comparisons, a p-value of p<0.005 was taken as the 
threshold for statistical significance. Binary logistic regression was used to test for any effects 
of oxytocin on performance in the positive control (memory) task. 
3. RESULTS
Food Intake
Table 2 presents mean scores for the eating measures and BMI. Intranasal oxytocin did not 
affect the amount of food consumed during the lunch (t(19) =-1.06, p = .30). However, 
intranasal oxytocin significantly reduced consumption of two of the test foods in the snack 
test. Specifically, the amount of chocolate biscuits eaten was significantly lower after 
oxytocin administration than after placebo administration (t(19) =-3.51, p = .002), and 
oxytocin also significantly reduced cracker consumption (t(19) =-3.52, p = .002). However, 
there was no significant difference between oxytocin and placebo conditions for the 
consumption of oatcakes (t(19) = -1.44, p = .167). Summing across food types, the total 
amount of test food consumed was significantly reduced by oxytocin (t(19) = 4.15, p = .001). 
Sweetness ratings for chocolate biscuits were higher in the oxytocin condition (t(19) = 2.14, p 
= .046), but not significantly so after adjustment for multiple comparisons (p >.005). The 
taste ratings for crackers and oatcakes were not significantly different between conditions 
(respectively: t(19) = -.42, p = .68; t(19) = -1.79, p = .09). As would be expected, BMI did 
not change between tests (t(19) = 0.96, p = .35).
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Table 2: Means and standard deviations for food intake (expressed as g and kcal for test 
foods) and taste measures after the administration of oxytocin or placebo; also mean BMI 
scores (N=20 per condition, repeated measures).
Other Measures
No differences were found between oxytocin and placebo conditions on VAS measures of 
PLACEBO OXYTOCIN
 MEASURE Mean SD Mean SD
 Lunch eaten (g) 187.6 6.3 181.6 25.2
 Chocolate biscuits eaten (g) 68.7 60.1 25.1 20.8
                                         (kcal) 344.2 301.1 125.8 104.2
 Crackers eaten                 (g) 19.4 18.0 5.7 6.8
                                         (kcal) 100.5 93.2 29.5 35.2
 Oatcakes eaten                (g) 5.6 7.5 3.1 1.9
                                         (kcal) 27.3 36.6 15.1 9.3
 Total amount of test foods eaten (g) 93.7 67.4 33.9 23.3
 Sweetness of chocolate cookies 
(VAS)
7.7 1.8 8.5 0.9
 Saltiness of crackers (VAS) 5.8 1.8 5.7 1.9
 Palatability of oatcakes (VAS) 3.5 2.3 2.5 1.9
 BMI (kg/m2) 25.5 3.1 25.4 3.0
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anxiety, happiness, excitement, alertness, hunger or thirst, nor did blood glucose levels differ 
between drug conditions at the time of the snack test. For the positive control task (face 
recognition), logistic regression indicated that participants were more likely to respond 
correctly to a new face under the influence of oxytocin, compared with placebo, but only 
when oxytocin was administered in the second session; Exp(B) = .30, p < .001. Thus, the 
findings in our version of the memory test did not fully align with those of Savaskan et al. 
(2008).
4. DISCUSSION
In a double-blind, crossover, placebo-controlled experiment, 24 IU of oxytocin significantly 
reduced the consumption of chocolate biscuits and salty crackers by 20 healthy men, 45 
minutes after drug administration. The reductions in consumption of both food types occurred 
postprandially, after having eaten a lunch, and in the absence of self-reported hunger. Anxiety 
and other aspects of mood were not affected by oxytocin. The results for food intake are 
strikingly consistent with those of Ott et al. (2013) and Thienel et al. (2016), which also 
found significant and pronounced effects of oxytocin on sweet-tasting carbohydrates 
specifically. In the present experiment, however, oxytocin reduced chocolate biscuit 
consumption to about one-third of placebo levels, whereas in Ott et al. (2013) the decline was 
was to about three-quarters of placebo levels. Sampling differences could account for this 
disparity, as the age range (25-27 years) and BMI  range (22.3 to 23.2 kg/m2) were much 
narrower in the study by Ott et al. (2013); in the subsequent study, the inclusion of obese 
participants may have contributed to an increased effect size (Thienel et al., 2016). Also, the 
chocolate biscuits were presented differently in our study, as whole (small) entities rather 
than as broken pieces. The results differ slightly from those of Lawson et al. (2015), who 
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only identified an effect of oxytocin when taking a combined macronutrient measure, with no 
selective effects on fat or carbohydrate subgroups, after controlling for multiplicity. 
Additionally, unlike any of the previous studies, the present experiment identified a 
significant reduction in salty snack consumption following oxytocin. Although this is the first 
report of oxytocin affecting intake of salty foods in humans, the finding is consistent with 
preclinical studies (e.g. Verbalis, Blackburn, Olson, & Stricker, 1993; Puryear, Rigatto, 
Amico, & Morris, 2001). The detection of an effect of oxytocin on salty food intake in the 
present study, in contrast with Ott et al. (2013), may reflect the shorter latency between drug 
administration and testing adopted here. 
There was a tendency for chocolate biscuits to be rated as sweeter in the oxytocin condition 
than in the placebo condition. Typically, increased sweetness might be expected to correlate 
with increased palatability and (therefore) intake; however, oxytocin significantly reduced 
intake. Post hoc analyses indicated that the reduction in consumption of chocolate biscuits 
was not directly related to ratings of sweetness (Pearson’s r = 0.01). Unfortunately, we did 
not test for the same taste parameters across all test foods, and so did not have ratings of 
general “palatability” for the chocolate biscuits to determine whether palatability was 
adversely affected by the elevated sense of sweetness. The absence of a general palatability 
measure makes it difficult to conclude that the intake of the more palatable test foods – 
chocolate biscuits and salty crackers - was specifically reduced by oxytocin regardless of 
whether the palatability was conferred by sweetness or saltiness. Ott et al. (2013) tested 
saltiness, sweetness, and palatability for each of the snack groups (bland, salty, and sweet), 
and only found the bland food to be rated more palatable after oxytocin. In contrast, we found 
no effect of oxytocin on oatcake palatability. However, the calories contained in the bland 
food used by Ott et al. (390 kcal/100g) were substantially lower than the calories found in the 
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salty and sweet foods (486 and 500 kcal/g respectively), meaning that the increased 
palatability rating in Ott et al.’s study could reflect a preference for low calorie foods in the 
oxytocin condition. In the present study, the test foods were also matched for calorie content 
(see Table 1). A need for more sophisticated characterization of taste properties in future 
studies is indicated in order to unpick the associations between sensation and behaviour. 
Currently, no study has reported associations between taste and intake that might logically 
underlie the effect of oxytocin. 
Relatedly, we were also unable to identify a mediating role for anxiety-relief in explaining 
the effects of oxytocin on eating. Oxytocin administration is often associated with decreased 
anxiety (Mccullough et al., 2013) and in the studies by both Ott et al. (2013) and Thienel et 
al. (2016) biological markers of anxiety were significantly lower in the oxytocin condition. 
The inability to detect oxytocin-induced changes in self-reported anxiety in the current study 
may reflect the insensitivity of the VAS measure used, although changes in levels of HPA 
axis hormones may not necessarily be correlated with changes in subjective state. The present 
outcome accords with the findings of a review of the safety and side effects of oxytocin, 
which concluded that participants were unable to detect the presence of oxytocin either 
physically or through its behavioural effects (Mccullough et al., 2013). Participants in the 
present study were no better than chance at guessing on which session oxytocin was 
administered, and the effects occurred in the absence of any discernible changes in scores on 
Rubin’s Romantic Love scale or on our other VAS mood scales. Together, these data suggest 
that individuals are unaware of measurable changes in their mood, behaviour or (more 
specifically) levels of anxiety brought about by oxytocin in a covert laboratory test. 
It is noteworthy that previous studies have not always fully disguised their research aims, 
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introducing the possibility of undesirable demand characteristics. In the present study, we are 
confident that we concealed the purpose of the study, since nobody was able to articulate the 
real purpose of the experiment when questioned after completing the second test session. 
However, researcher effects may have been generated by (for example) the use of a female 
experimenter and an exclusively male, heterosexual cohort. It is not obvious how such effects 
may have operated to produce the drug-specific anorectic outcomes that we identified, but 
one possible route of influence is by affecting baseline eating propensity, which may in turn 
facilitate the detection of a drug effect. The instruction that the taste-test foods would be 
discarded if not eaten may have encouraged eating under oxytocin if the drug’s prosocial 
actions included an increase in desire to avoid wastefulness in a social situation; however, the 
procedure is common to many studies that examine how particular variables affect food 
intake (including Ott et al., 2013). The role of the experimenter in modulating the effects of 
psychoactive drugs is a research issue that deserves further exploration (e.g. see Felisberti 
and Terry, 2015), particularly for a compound with prosocial effects, like oxytocin (Striepens, 
Kendrick, Maier, & Hurlemann, 2011).
Perhaps surprisingly, the pharmacokinetics of oxytocin are still not fully understood. A 
number of mechanisms have been proposed to explain how intranasal oxytocin might reach 
the brain (Dhuria, Hanson, & Frey, 2010), none of which have yet been ruled out (Madara, 
2000). Neuropeptides have been detected in CSF just 10 minutes after intranasal application 
(Born et al., 2002), and intranasal oxytocin demonstrably enters CSF in primates (Lee, 
Scheidweiler, Diao, et al., 2018). Measurable effects from intranasal oxytocin have been 
reported in humans 30 minutes after administration (Savaskan, Ehrhardt, Schulz, Walter, & 
Schächinger, 2008). The contrasting latencies between drug administration and the first 
opportunity to eat, which were 15 minutes (to lunch) in this experiment and 45 minutes in Ott 
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et al.’s study (2013), made no difference: neither latency was associated with changes to 
appetite during this phase. However, the latencies between drug and snack-test also differed 
substantially between the two studies: 45 minutes here and 175 minutes in Ott et al. (2013); 
hence we demonstrated similar anorectic effects at a much shorter post-drug latency than 
reported previously. The speed of response in the current study would seem to rule out 
intracellular transmission as a mode of drug transport to the relevant receptors. More 
generally, the broad temporal range of oxytocin’s efficacy at reducing food intake in the 
laboratory suggests that oxytocin’s efficacy is not tightly reliant on time of administration. 
This could be important, given the potential difficulties for overeaters in maintaining a fixed 
eating regime (Zhang et al., 2013). However, a study in mice has shown the rapid 
development of tolerance to the anorectic effects of an oxytocin receptor agonist administered 
intranasally: the effects were negligible by day three of daily exposure (Olson et al., 1991). 
The possibility of tolerance in humans is yet to be explored, but a recent meta-analysis found 
that oxytocin becomes less effective at inhibiting eating with chronic administration (Leslie, 
Silva, Paloyelis, Blevins, & Treasure, 2018). Nevertheless, the potential for oxytocin to be an 
effective agent for dietary control with a practically-achievable dosage regimen supports the 
need for further research, particularly given the difficulties that many people would 
inevitably encounter in trying to maintain rigid schedules of drug administration and food 
consumption. 
                                                                                                                           
Intranasal oxytocin’s effect on appetite has not yet been investigated in a normal-eating 
female cohort, which, given oxytocin’s sexually dimorphic central expression (Ochedalski, 
Subburaju, Wynn, & Aguilera, 2007; Patisaul, Scordalakes, Young, & Rissman, 2003), is an 
important research area that still needs to be addressed. In female mice, oxytocin reduces 
appetite for sweet-tasting foodstuffs and curtails feeding in response to hyperosmotic and 
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lithium-induced toxicity (Flanagan, Verbalis, & Stricker, 1989; Verbalis,et al., 1993). 
However, oxytocin has a regulatory osmotic role unique to rodents that may make 
translational inferences unreliable (Blackburn, Samson, Fulton, Stricker, & Verbalis, 1995). 
More research with female participants is essential.
In conclusion, the current study identified significant anorectic effects of oxytocin on post-
prandial food consumption, effects that are consistent with the limited number of studies that 
have been conducted to date. The consumption of a salty-food type as well as a sweet-food 
type was reduced by oxytocin, a novel finding consistent with animal data (Puryear, Rigatto, 
Amico, & Morris, 2001; Verbalis et al., 1993) The study has also demonstrated that such 
effects can be obtained within a much shorter timeframe after drug administration (45 
minutes) than has been demonstrated in previous studies of oxytocin’s anorectic effects.
Lee, M.R., Scheidweiler, K.B., Diao, X.X., Akhlaghi, F., Cummins, A., Huestis, M.A., 
Leggio, L., & Averbeck, B.B. (2018) Oxytocin by intranasal and intravenous routes reaches 
the cerebrospinal fluid in rhesus macaques: determination using a novel oxytocin assay. 
Molecular Psychiatry, 23, 115-122 
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